EQ-302

N/A

Report date: 2025/04/24 10:41:07
NMEFirst In Class

Base Information

Drug NameEQ-302
Drug Alias NameEQ302EQ-302
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin-15 inhibitorsInterleukin-21 inhibitors
TargetsInterleukin-15Interleukin-21
Therapy Area/IndicationsCeliac DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEquillium Inc
China Registration ClassN/A

Develop Information

Active CompaniesEquillium Inc
Inactive CompaniesN/A
Active IndicationsCeliac DiseaseInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A